NCT04695431 2022-01-10
Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
Blueprint Medicines Corporation
Completed
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Adelphi Values LLC